breast cancer

Drug used for menorrhagia may prevent postpartum hemorrhageA drug that is low cost and easy to administer may help prevent maternal deaths, according to results of a randomized clinical trial. Plus: Does air pollution affect menstrual regularity? Also: According to a statement published by the American Heart Association (AHA), breast cancer patients may be at increased risk of cardiovascular disease (CVD).
Seven Ways to Help Patients Access Costly Cancer DrugsTwo new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.
Cancer Vaccine to Prevent Breast, Ovarian Cancer Recurrence Could be CloseIn partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
What impact does maternal obesity have on fetal growth?Results of a study of fetal ultrasounds show that maternal obesity has an impact on fetal growth as early as 32 weeks’ gestation. Plus: Breast cancer risks increased by 21% in women who consumed more than 9 g of processed meat per day, according to a published study. Also: Does prenatal use of topiramate increase risk of cleft palate?
FDA approves first drug for breast cancer with BRCA geneFDA approved the first drug to treat certain patients with metastatic breast cancer who have a “BRCA” gene mutation.
Top 3 new drug approvalsHere are 3 of the top new drug approvals in late December and early January.
Hormonal contraception and breast cancer: Is there a link?Results of a prospective cohort study by Danish investigators suggest that current or recent use of hormonal contraceptives may be associated with an increased risk of breast cancer. Plus, Editorial Board Member, Ilana Cass, MD, weighs in on the impact of the study's findings.
Hereditary cancers in gynecology:  What clinicians need to know
Hereditary cancers in gynecology: What clinicians need to knowThe contribution of hereditary cancer syndromes to many gynecologic malignancies has been increasingly recognized over the past decade. As they often serve as primary care providers, ob/gyns are uniquely positioned to help identify at-risk women before they develop cancer.
New cancer biosimilar could net major sales
New cancer biosimilar could net major salesA new biosimilar to the cancer drug Herceptin, which raked in $2.5 billion in US sales last year, is expected to produce blockbuster sales in the US.
FDA approves breakthrough cancer gene test
FDA approves breakthrough cancer gene testFDA approved a new cancer biomarker test that can detect genetic mutations in 324 genes and 2 genomic signatures in tumors.